Clinical Trial

A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment

Study acronym: PATH
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to provide continued access to the study treatment for participants from previous ViiV Healthcare studies who are still benefiting from it and do not have local access after completing the parent study. This continued access will also allow further collection of safety data. Eligible participants are those who completed a ViiV Healthcare-sponsored or collaborative parent study and are currently experiencing clinical benefit. The Sponsor will periodically review the study to consider other treatment access options.
Protocol Amendment History 4 changes
critical Recruitment opened 2026-08-15
notable Trial sites expanded: 0 -> 4 locations 2026-08-15
notable Primary completion pushed: 2030-12-30 -> 2032-09-14 2026-08-15
minor Completion pushed: 2030-12-30 -> 2032-09-14 2026-08-15
Trial Details
NCT Number NCT07393659
Lead Sponsor ViiV Healthcare
Conditions HIV Infections
Enrollment 181 participants
Start Date 2026-07-21
Primary Completion 2032-09-14 (estimated)
Study Completion 2032-09-14 (estimated)
Updated on ClinicalTrials.gov 2026-08-14